CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015] On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 9 years ago You may also like 52:31 Affinity Duchenne™ and Affinity Beyond™: Updates on Investigational RGX-202 from REGENXBIO 1 year ago Research & Clinical Trial Webinars,Webinars 31:23 Advocating for Access: Insurance 101 1 year ago Care Webinars,Webinars 29:12 Advocating for Access: Navigating Approved Therapies in Duchenne 1 year ago Care Webinars,Webinars 1:11:00 Webinar: ELEVIDYS Approval: What this means for you and your family 1 year ago Care Webinars,Webinars 46:01:00 Webinar: ENVISION Study Update with Sarepta Therapeutics 1 year ago Research & Clinical Trial Webinars,Webinars 37:54 Community Town Hall: SRP-9001 Advisory Committee Update (May 2023) 1 year ago Research & Clinical Trial Webinars,Webinars 55:52 Webinar: Edgewise — A Novel Approach Designed to Protect Muscle in Becker (May 2023) 2 years ago Research & Clinical Trial Webinars,Webinars 48:49 Webinar: Dyne Therapeutics — Advancing FORCE in the Pursuit of Therapies (April 2023) 2 years ago Research & Clinical Trial Webinars,Webinars «123456…25»Page 4 of 25
by: Parent Project Muscular Dystrophy
